193 related articles for article (PubMed ID: 38328920)
1. Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies.
Sharma N; Kurmi BD; Singh D; Mehan S; Khanna K; Karwasra R; Kumar S; Chaudhary A; Jakhmola V; Sharma A; Singh SK; Dua K; Kakkar D
J Drug Target; 2024 Jun; 32(5):457-469. PubMed ID: 38328920
[TBL] [Abstract][Full Text] [Related]
2. Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omics.
Shin TH; Manavalan B; Lee DY; Basith S; Seo C; Paik MJ; Kim SW; Seo H; Lee JY; Kim JY; Kim AY; Chung JM; Baik EJ; Kang SH; Choi DK; Kang Y; Mouradian MM; Lee G
Part Fibre Toxicol; 2021 Nov; 18(1):42. PubMed ID: 34819099
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-based toxicity in perishable vegetable crops: Molecular insights, impact on human health and mitigation strategies for sustainable cultivation.
Sharma S; Shree B; Aditika ; Sharma A; Irfan M; Kumar P
Environ Res; 2022 Sep; 212(Pt A):113168. PubMed ID: 35346658
[TBL] [Abstract][Full Text] [Related]
4. Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery.
Das J; Choi YJ; Song H; Kim JH
Hum Reprod Update; 2016 Sep; 22(5):588-619. PubMed ID: 27385359
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of nanoparticle toxicity to cyanobacteria.
Kumar M; Sabu S; Sangela V; Meena M; Rajput VD; Minkina T; Vinayak V; Harish
Arch Microbiol; 2022 Dec; 205(1):30. PubMed ID: 36525087
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic nanostructures and nanotoxicity.
Sarma A; Bania R; Devi JR; Deka S
J Appl Toxicol; 2021 Oct; 41(10):1494-1517. PubMed ID: 33641187
[TBL] [Abstract][Full Text] [Related]
7. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy.
Wang Y; Santos A; Evdokiou A; Losic D
J Mater Chem B; 2015 Sep; 3(36):7153-7172. PubMed ID: 32262822
[TBL] [Abstract][Full Text] [Related]
8. Review of the effects of manufactured nanoparticles on mammalian target organs.
Wu T; Tang M
J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function.
Uzhytchak M; Smolková B; Lunova M; Frtús A; Jirsa M; Dejneka A; Lunov O
Adv Drug Deliv Rev; 2023 Jun; 197():114828. PubMed ID: 37075952
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials and nanoparticles: sources and toxicity.
Buzea C; Pacheco II; Robbie K
Biointerphases; 2007 Dec; 2(4):MR17-71. PubMed ID: 20419892
[TBL] [Abstract][Full Text] [Related]
11. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
Lai DY
Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
[TBL] [Abstract][Full Text] [Related]
12. Toxicogenomics: A New Paradigm for Nanotoxicity Evaluation.
Dwivedi S; Saquib Q; Ahmad B; Ansari SM; Azam A; Musarrat J
Adv Exp Med Biol; 2018; 1048():143-161. PubMed ID: 29453537
[TBL] [Abstract][Full Text] [Related]
13. Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.
Umair M; Javed I; Rehman M; Madni A; Javeed A; Ghafoor A; Ashraf M
J Pharm Pharm Sci; 2016; 19(2):161-80. PubMed ID: 27518167
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle Toxicology.
Yang W; Wang L; Mettenbrink EM; DeAngelis PL; Wilhelm S
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():269-289. PubMed ID: 32841092
[TBL] [Abstract][Full Text] [Related]
15. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems.
Sharma A; Madhunapantula SV; Robertson GP
Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):47-69. PubMed ID: 22097965
[TBL] [Abstract][Full Text] [Related]
16. Nanotoxicity: oxidative stress mediated toxicity of metal and metal oxide nanoparticles.
Sarkar A; Ghosh M; Sil PC
J Nanosci Nanotechnol; 2014 Jan; 14(1):730-43. PubMed ID: 24730293
[TBL] [Abstract][Full Text] [Related]
17. Integration of metabolomics and transcriptomics in nanotoxicity studies.
Shin TH; Lee DY; Lee HS; Park HJ; Jin MS; Paik MJ; Manavalan B; Mo JS; Lee G
BMB Rep; 2018 Jan; 51(1):14-20. PubMed ID: 29301609
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery and nanoparticles:applications and hazards.
De Jong WH; Borm PJ
Int J Nanomedicine; 2008; 3(2):133-49. PubMed ID: 18686775
[TBL] [Abstract][Full Text] [Related]
19. Nanotoxicity of multifunctional stoichiometric cobalt oxide nanoparticles (SCoONPs) with repercussions toward apoptosis, necrosis, and cancer necrosis factor (TNF-α) at nano-biointerfaces.
Kumar R; Chhikara BS; Er Zeybekler S; Gupta DS; Kaur G; Chhillar M; Aggarwal AK; Rahdar A
Toxicol Res (Camb); 2023 Oct; 12(5):716-740. PubMed ID: 37915472
[TBL] [Abstract][Full Text] [Related]
20. Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death.
Khanna P; Ong C; Bay BH; Baeg GH
Nanomaterials (Basel); 2015 Jun; 5(3):1163-1180. PubMed ID: 28347058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
